Drawing for SEE MORE. TREAT SMARTER.

USPTO serial 86764515

SEE MORE. TREAT SMARTER.

Reviewed by CopyMark Law Group

Reg. 5205582Status 702Renewal
Filing date
Status date
Registration date
May 16, 2017
Examiner
BROOKSHIRE, DAVID AARON
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SEE MORE. TREAT SMARTER.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori A. Ruhly

Lori A. Ruhly Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, medicinal substances, namely, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, drug delivery agents, namely, preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; transarterial chemoembolisation pharmaceutical preparations [; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, therapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer ]ACTIVEDec 23, 2015
010[Surgical, medical apparatus and instruments, namely, medical device, apparatus and instruments for treating cancer; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system;] embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolization, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; [ drug delivery embolisation systems; drug delivery apparatus and instruments namely, a drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system;] medical apparatus and instruments for embolization, namely, medical devices in the nature of particles, namely, embolic microspheres for embolization [ ; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for use in the circulatory system; surgical and medical apparatus for use in treatment of, arterio-venous malformations; syringes for use in treatment of, arterio-venous malformations ]ACTIVEDec 23, 2015
041[ Education, namely, developing, arranging and conducting educational seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; providing computer, electronic and online databases featuring information about medical education in the field of healthcare, medicine, medical treatment and patient care; training in the use and operation of pharmaceutical products, pharmaceutical preparations, radiopharmaceutical preparations, medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical and medical devices, medical research, surgery, medical science, medicine and medical diseases, disorders and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues ]SECTION 8 - CANCELLEDJan 26, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 15, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 15, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 9, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 9, 2024XXXXPOST REGISTRATION ACTION CORRECTION—
Oct 8, 2024EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Oct 2, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 2, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 2, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 2, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 21, 2024PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
May 20, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 16, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Mar 16, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 16, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 16, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 16, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 16, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 29, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 29, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 29, 2020EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Aug 29, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 29, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 16, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 11, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 8, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 17, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 16, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 6, 2017IUAFUSE AMENDMENT FILED—
Mar 6, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 6, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 12, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 12, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 2, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jun 2, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 2, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 2, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
May 17, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 16, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2016DOCKASSIGNED TO EXAMINER—
Sep 28, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance